Dr. Ann Anderson has served as the Director of Pathology at Integrated Medical Professionals since 2008, following 20 years at the Northwell Health System. With a strong foundation in Molecular Biology and Tumor Cytogenetics from Memorial Sloan Kettering Cancer Center (MSKCC), she pioneered the implementation of the first Physician Office Lab Shotgun Metagenomics platform for persistent urinary tract infections.

In recent years, her team has focused on advancing a comprehensive Prostate Cancer Germline Initiative (NIH 508511) , which encompasses in-house sequencing, diagnostic services, and educational programs for both physicians and patients. This initiative underscores
the critical significance of NCCN-recommended germline studies for high-risk prostate cancer patients. The next phase of this work involves transitioning to in-house somatic testing, which is currently in progress.

Dr. Anderson earned her M.D. from New York Medical College and completed her studies in Molecular Biology and Tumor Cytogenetics at MSKCC with Dr. Raju Chaganti.